Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations.
BACKGROUND: Amniotic fluid embolism (AFE) is a rare but severe complication of pregnancy. A recent systematic review highlighted apparent differences in the incidence, with studies estimating the incidence of AFE to be more than three times higher in North America than Europe. The aim of this study...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2012
|
| _version_ | 1797051438404206592 |
|---|---|
| author | Knight, M Berg, C Brocklehurst, P Kramer, M Lewis, G Oats, J Roberts, C Spong, C Sullivan, E van Roosmalen, J Zwart, J |
| author_facet | Knight, M Berg, C Brocklehurst, P Kramer, M Lewis, G Oats, J Roberts, C Spong, C Sullivan, E van Roosmalen, J Zwart, J |
| author_sort | Knight, M |
| collection | OXFORD |
| description | BACKGROUND: Amniotic fluid embolism (AFE) is a rare but severe complication of pregnancy. A recent systematic review highlighted apparent differences in the incidence, with studies estimating the incidence of AFE to be more than three times higher in North America than Europe. The aim of this study was to examine population-based regional or national data from five high-resource countries in order to investigate incidence, risk factors and outcomes of AFE and to investigate whether any variation identified could be ascribed to methodological differences between the studies. METHODS: We reviewed available data sources on the incidence of AFE in Australia, Canada, the Netherlands, the United Kingdom and the USA. Where information was available, the risk factors and outcomes of AFE were examined. RESULTS: The reported incidence of AFE ranged from 1.9 cases per 100 000 maternities (UK) to 6.1 per 100 000 maternities (Australia). There was a clear distinction between rates estimated using different methodologies. The lowest estimated incidence rates were obtained through validated case identification (range 1.9-2.5 cases per 100 000 maternities); rates obtained from retrospective analysis of population discharge databases were significantly higher (range 5.5-6.1 per 100 000 admissions with delivery diagnosis). Older maternal age and induction of labour were consistently associated with AFE. CONCLUSIONS: Recommendation 1: Comparisons of AFE incidence estimates should be restricted to studies using similar methodology. The recommended approaches would be either population-based database studies using additional criteria to exclude false positive cases, or tailored data collection using existing specific population-based systems.Recommendation 2: Comparisons of AFE incidence between and within countries would be facilitated by development of an agreed case definition and an agreed set of criteria to minimise inclusion of false positive cases for database studies.Recommendation 3: Groups conducting detailed population-based studies on AFE should develop an agreed strategy to allow combined analysis of data obtained using consistent methodologies in order to identify potentially modifiable risk factors.Recommendation 4: Future specific studies on AFE should aim to collect information on management and longer-term outcomes for both mothers and infants in order to guide best practice, counselling and service planning. |
| first_indexed | 2024-03-06T18:19:34Z |
| format | Journal article |
| id | oxford-uuid:05cfda0f-2a28-4f5d-8289-5ff6348da661 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:19:34Z |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:05cfda0f-2a28-4f5d-8289-5ff6348da6612022-03-26T08:59:11ZAmniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:05cfda0f-2a28-4f5d-8289-5ff6348da661EnglishSymplectic Elements at OxfordBioMed Central2012Knight, MBerg, CBrocklehurst, PKramer, MLewis, GOats, JRoberts, CSpong, CSullivan, Evan Roosmalen, JZwart, J BACKGROUND: Amniotic fluid embolism (AFE) is a rare but severe complication of pregnancy. A recent systematic review highlighted apparent differences in the incidence, with studies estimating the incidence of AFE to be more than three times higher in North America than Europe. The aim of this study was to examine population-based regional or national data from five high-resource countries in order to investigate incidence, risk factors and outcomes of AFE and to investigate whether any variation identified could be ascribed to methodological differences between the studies. METHODS: We reviewed available data sources on the incidence of AFE in Australia, Canada, the Netherlands, the United Kingdom and the USA. Where information was available, the risk factors and outcomes of AFE were examined. RESULTS: The reported incidence of AFE ranged from 1.9 cases per 100 000 maternities (UK) to 6.1 per 100 000 maternities (Australia). There was a clear distinction between rates estimated using different methodologies. The lowest estimated incidence rates were obtained through validated case identification (range 1.9-2.5 cases per 100 000 maternities); rates obtained from retrospective analysis of population discharge databases were significantly higher (range 5.5-6.1 per 100 000 admissions with delivery diagnosis). Older maternal age and induction of labour were consistently associated with AFE. CONCLUSIONS: Recommendation 1: Comparisons of AFE incidence estimates should be restricted to studies using similar methodology. The recommended approaches would be either population-based database studies using additional criteria to exclude false positive cases, or tailored data collection using existing specific population-based systems.Recommendation 2: Comparisons of AFE incidence between and within countries would be facilitated by development of an agreed case definition and an agreed set of criteria to minimise inclusion of false positive cases for database studies.Recommendation 3: Groups conducting detailed population-based studies on AFE should develop an agreed strategy to allow combined analysis of data obtained using consistent methodologies in order to identify potentially modifiable risk factors.Recommendation 4: Future specific studies on AFE should aim to collect information on management and longer-term outcomes for both mothers and infants in order to guide best practice, counselling and service planning. |
| spellingShingle | Knight, M Berg, C Brocklehurst, P Kramer, M Lewis, G Oats, J Roberts, C Spong, C Sullivan, E van Roosmalen, J Zwart, J Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title | Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title_full | Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title_fullStr | Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title_full_unstemmed | Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title_short | Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. |
| title_sort | amniotic fluid embolism incidence risk factors and outcomes a review and recommendations |
| work_keys_str_mv | AT knightm amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT bergc amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT brocklehurstp amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT kramerm amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT lewisg amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT oatsj amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT robertsc amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT spongc amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT sullivane amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT vanroosmalenj amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations AT zwartj amnioticfluidembolismincidenceriskfactorsandoutcomesareviewandrecommendations |